The average one-year price target for Core Laboratories (NYSE:CLB) has been revised to $15.64 / share. This is an increase of 11.51% from the prior estimate of $14.02 dated September 27, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $10.10 to a high of $23.10 / share. The average price target represents a decrease of 5.04% from the latest reported closing price of $16.47 / share.
What is the Fund Sentiment?
There are 420 funds or institutions reporting positions in Core Laboratories. This is an increase of 2 owner(s) or 0.48% in the last quarter. Average portfolio weight of all funds dedicated to CLB is 0.07%, an increase of 22.42%. Total shares owned by institutions increased in the last three months by 5.37% to 70,483K shares. 
The put/call ratio of CLB is 0.76, indicating a bullish outlook.
What are Other Shareholders Doing?
Ariel Investments holds 12,976K shares representing 27.87% ownership of the company. In its prior filing, the firm reported owning 10,342K shares , representing an increase of 20.30%. The firm decreased its portfolio allocation in CLB by 6.99% over the last quarter.
Disciplined Growth Investors holds 5,441K shares representing 11.68% ownership of the company. In its prior filing, the firm reported owning 5,492K shares , representing a decrease of 0.93%. The firm decreased its portfolio allocation in CLB by 29.65% over the last quarter.
ARGFX - Ariel Fund Investor Class holds 5,219K shares representing 11.21% ownership of the company. In its prior filing, the firm reported owning 3,661K shares , representing an increase of 29.85%. The firm increased its portfolio allocation in CLB by 11.36% over the last quarter.
Earnest Partners holds 3,603K shares representing 7.74% ownership of the company. In its prior filing, the firm reported owning 3,630K shares , representing a decrease of 0.76%. The firm decreased its portfolio allocation in CLB by 28.19% over the last quarter.
IJR - iShares Core S&P Small-Cap ETF holds 2,803K shares representing 6.02% ownership of the company. In its prior filing, the firm reported owning 2,893K shares , representing a decrease of 3.20%. The firm decreased its portfolio allocation in CLB by 26.17% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
